Waystar Finalizes Pricing for Significant Secondary Stock Offering

Waystar, a prominent leader in healthcare payments software, has officially announced the final pricing for its highly anticipated secondary offering of common stock. The company confirmed that 20,000,000 shares of its common stock have been priced at $17.00 per share, marking a crucial development for its financial landscape and existing investors.

This substantial offering involves shares being sold by affiliates of EQT Private Equity and the Canada Pension Plan Investment Board (CPPIB), both key long-term investors in Waystar.

It is important for the market to understand that Waystar itself will not receive any proceeds from the sale of these shares; all net proceeds from this transaction will go directly to the selling stockholders.

The offering is being expertly managed by a powerful syndicate of leading financial institutions.

J.P. Morgan is taking the helm as the sole book-running manager, demonstrating its confidence in Waystar's market position. They are strongly supported by Goldman Sachs & Co. LLC, Barclays, and RBC Capital Markets, who are acting as joint book-running managers, ensuring broad market reach and robust execution.

In a standard provision designed to facilitate market demand, the underwriters have been granted a 30-day option.

This option allows them to purchase up to an additional 3,000,000 shares of common stock from the selling stockholders, providing flexibility and an opportunity to adjust the offering size based on market interest.

For those seeking comprehensive details, the offering is being made pursuant to Waystar’s registration statement on Form S-1, which has been formally filed with the U.S.

Securities and Exchange Commission (SEC) and was recently declared effective. Interested parties are encouraged to consult these official filings for complete and accurate information regarding the terms and conditions of the offering. A preliminary prospectus supplement detailing the offering is also accessible via the SEC's EDGAR database.

This secondary offering signifies a strategic financial move by Waystar's major institutional investors to optimize their portfolios, while simultaneously affirming the continued market interest and liquidity surrounding Waystar as it progresses in its mission to simplify the complex world of healthcare payments.